Abstract

BackgroundAsthenozoospermia is a chief reason for male seminal pathologies with an impression of around 19% of infertile patients. Spermatozoa mitochondrial DNA variations seem to link with low sperm motility. The objective of the study was to assess the relation between mitochondrial mutations and male sterility, especially in asthenozoospermia. The patient semen samples were investigated by studying the sperm physical characters; motility, viability, and morphological parameters were then classified into normozoospermia and asthenozoospermia. In addition, the level of malondialdehyde (MDA) as a bio-indicator of lipid peroxidation, seminal fructose, and total antioxidant capacity (TAC) were estimated. For molecular analysis, DNA from the semen samples was extracted using a DNA extraction kit. ND1, ND2, and ATPase6 genes were amplified by using a specific primer. After the purification procedure, each PCR product was sequenced to identify the single nucleotide polymorphisms (SNPs) in selected genes. ResultsA significant negative correlation between seminal plasma malondialdehyde levels and sperm motility was detected. Meanwhile, TAC analysis revealed significantly lower activity (p ≤ 0.05) in the sample of asthenozoospermic than in normozoospermic men. As regards the seminal plasma fructose, there was no significant difference in the fructose level of normozoospermia and asthenozoospermia cases. At the molecular level, 31 diverse nucleotide substitutions were recognized in mitochondrial DNA. Only ten (10) mutations led to amino acid transformation: four have deleterious effects, four are benign, and the other two have conflicting effectiveness. ConclusionsThis study is the first in Egypt that is concerned with studying the relationship between the mitochondrial DNA mutations in human spermatozoa of asthenozoospermic patients and fertility. The results displayed scientific indications evidenced that there is an association between mitochondrial mutations and male infertility.

Highlights

  • Asthenozoospermia is a chief reason for male seminal pathologies with an impression of around 19% of infertile patients

  • The seminal total antioxidant capacity test revealed significantly lower activity in asthenozoospermia (p ≤ 0.05) compared to normozoospermia, whereas the results of seminal plasma fructose indicated there was no significant difference in the fructose level of normozoospermia and asthenozoospermia cases

  • This suggests that infertile patients undergo oxidative stressinduced lipid peroxidation, where malondialdehyde is an important marker for oxidative stress

Read more

Summary

Introduction

Asthenozoospermia is a chief reason for male seminal pathologies with an impression of around 19% of infertile patients. The patient semen samples were investigated by studying the sperm physical characters; motility, viability, and morphological parameters were classified into normozoospermia and asthenozoospermia. Male infertility denotes male’s incapability to cause fertile female pregnancy. Asthenozoospermia is a chief reason for male seminal pathologies that impact around 19% of infertile patients. It is characterized by decreasing progressively motile percentage (PR) spermatozoa under 32% [5]. The specific gene defect association and any deformities of these factors could be accountable for poor sperm motility and sterility [6]. Sperm motility is the origin of the sperm tail flagella movement by ATP-derived energy, formed in the mid-piece positioned mitochondrion [7]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call